Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PHVS -8.4%, LNN -3.5%, SMG -2.4% (guidance)
Other news:
- INO -21.8% (proposes public offering of stock and warrants)
- ADAG -13.2% (announces results from the latest data cut from its Phase 1b/2 study of muzastotug in patients with advanced microsatellite stable colorectal cancer with no liver metastases)
- ANRO -12.4% (topline data from Phase 2 proof-of-concept study of ALTO-101)
- SKE -8.5% (announces pricing of $750 million senior secured notes offering to refinance former project financing and to fund partial buyback of existing gold stream)
- IMVT -7.4% (reports Phase 3 study results for Batoclimab in Thyroid Eye Disease)
- LUNR -6.8% (stock offering by selling shareholders)
- WPM -5.5% (to acquire gold and silver stream on Jervois project in Australia; closes $4.3 bln silver stream deal with BHP on Antamina mine)
- KRMN -5.1% (to delay 10-K)
- CLDX -3.6% (prices offering of 10,345,000 shares of common stock at $29.00 per share)
- CVBF -2.6% (receipt of regulatory approvals for merger with HTBK)
- APO -2.5% (preliminary estimates for Q1 alternative net investment income)
- CVGI -2.3% (CFO to resign; reaffirms revenue guidance)
- GILD -1.6% (extends expiration date of tender offer to acquire Arcellx)
- KMTS -1.5% (files for common share offering)
- UMH -1.4% (Q1 operation update)